Table 3.
Correlation between FMNL1 proten expression level and clinicopathological parameters of ccRCC
| Clinicopathological Parameters | n | FMNL1 protein expression level | χ2 | p* | |
|---|---|---|---|---|---|
| Low | High | ||||
| Age | |||||
| <61 | 29 | 18 | 11 | 3.820 | 0.051 |
| ≥61 | 23 | 8 | 15 | ||
| Gender | |||||
| Male | 28 | 16 | 12 | 1.248 | 0.266 |
| Female | 24 | 10 | 14 | ||
| T stage | |||||
| T1, T2 | 38 | 20 | 18 | 2.383 | 0.123 |
| T3, T4 | 14 | 4 | 10 | ||
| N stage | |||||
| N0 | 40 | 22 | 18 | 1.733 | 0.188 |
| N1 | 12 | 4 | 8 | ||
| M stage | |||||
| M0 | 42 | 24 | 18 | 4.457 | 0.035 |
| M1 | 10 | 2 | 8 | ||
| AJCC stage | |||||
| I or II | 36 | 22 | 14 | 5.778 | 0.016 |
| III or IV | 16 | 4 | 12 | ||
| Fuhrman grade | |||||
| 1,2 | 25 | 17 | 8 | 6.240 | 0.012 |
| 3.4 | 27 | 9 | 18 | ||
*p<0.05 was considered as significant.